CBS Evening News, May 11, 2020
White House directs staff to wear face masks in the West Wing; Some imported face masks failing to protect first responders from coronavirus
Food and Drug Administration
CBS Evening News, May 1, 2020
Protests intensify as dozens of states ease restrictions; Kids across America air minor lockdown grievances
CBS Evening News, August 25th, 2020
Hurricane Laura could make landfall on Gulf Coast as a Category 3 storm; Hospital guard turned medical student strives to help others achieve their dreams
Gottlieb says Omicron variant "almost definitely" already in U.S.
Dr. Scott Gotlieb, the former FDA commissioner, says vaccines and boosters could provide a "backstop" against the latest variant of the coronavirus.
A new Alzheimer's drug brings hope, controversy
The FDA's recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer's disease. But the approval process for Aduhelm has stirred controversy. Correspondent Susan Spencer talks with experts about the clinical benefits of this new class of drugs; and with early-onset Alzheimer's patients, including a former neurologist who enrolled in an early trial of Aduhelm.
U.S. COVID-19 death toll in 2021
Coronavirus cases are rising in more than 30 states ahead of Thanksgiving. It comes as the White House reports about 3 million Americans received a third dose over the weekend following the FDA's authorization of both Moderna and Pfizer's booster for all adults. Vice Dean of Johns Hopkins University's Bloomberg School of Public Health Dr. Joshua Sharfstein joined CBSN's Elaine Quijano to discuss.
Moderna asks FDA to clear booster for all adults
Moderna has formally requested the FDA authorize expansion of its COVID-19 booster shot to all adults. Federal health officials are expected to authorize expansion of Pfizer's booster this week. It comes as cases continue to rise across the U.S. Emergency medicine physician Dr. Owais Durrani joins CBSN's Lana Zak to discuss.
U.S. lines up deal with Pfizer for COVID-19 treatment pill
The pharmaceutical giant has asked the federal regulators to authorize the experimental pill, called Paxlovid.
Pfizer booster may get OK for all U.S. adults
The Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine booster shot for all adults in the U.S. as soon as this week. Pfizer is also seeking emergency-use authorization for its COVID antiviral pill. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
FDA may authorize Pfizer booster shots for all adults this week
The drugmaker filed for emergency use authorization last week.
Pfizer files for emergency authorization of its COVID-19 pill
The drugmaker is asking regulators to authorize its experimental coronavirus pill for people with mild to moderate infections.
Pfizer seeks authorization for antiviral COVID pill
Pfizer is requesting FDA authorization of its antiviral COVID-19 pill. The company's study found it is nearly 90% effective in cutting hospitalizations and deaths from the virus. Meanwhile, at least 20 states are experiencing upticks in infections. Infectious disease physician at the University of Michigan Dr. Payal Patel joins CBSN's Elaine Quijano to discuss the latest pandemic news.
COVID cases on the rise ahead of Thanksgiving
The CDC reports over 1 million children ages 5 to 11 have received the first dose of Pfizer's pediatric vaccine. This comes as several states and New York City begin expanding booster eligibility to all adults. Director of vaccine research at Cincinnati Children's Hospital, Dr. Robert Frenck, joins CBSN's Elaine Quijano with a look at the day's pandemic news.
Using psychedelics to treat veterans' PTSD
Some suffering from Post-Traumatic Stress Disorder have had little relief from traditional anti-depressants; now, a recent FDA-approved trial using MDMA – a.k.a. ecstasy – has shown promising results.
Biden taps Robert Califf for FDA commissioner, and Manchin opposes
Califf also served in this role during the Obama administration.
Pfizer asks FDA to allow boosters for all adults
Pfizer is asking the FDA to authorize use of its COVID-19 booster shot for all U.S. adults age 18 and over. Meanwhile, the vaccine rollout of the lower-dose Pfizer vaccine for kids ages 5 to 11 is underway. Dr. Susannah Hills, a pediatric airway surgeon, joined CBSN to discuss the latest coronavirus headlines.
Pfizer asks FDA to expand booster eligibility
Pfizer has asked the FDA to authorize its COVID-19 vaccine booster shots for Americans 18 and older. As CBS News' Nikki Battiste reports, a third dose has only been authorized for those who are 65 and older or at high risk for the virus. Then, Dr. Angela Myers, director of the infectious diseases division at Children's Mercy Kansas City, joins CBSN's Elaine Quijano to discuss the latest on the pandemic.
Pfizer seeks FDA authorization for COVID booster
Pfizer asked the FDA to authorize booster doses of its COVID-19 vaccine for all adults, ages 18 and older. Right now, it's only authorized for seniors and high-risk adults. Nikki Battiste has the latest.
The push to get kids vaccinated against COVID
The Food and Drug Administration authorized a smaller dose of Pfizer's COVID-19 vaccine for children ages 5 to 11 on Tuesday. By Wednesday morning, parents were lining up to get their kids vaccinated. While some are choosing to wait, many parents are relieved they can finally give their kids some protection from COVID. Michael George reports.
FDA authorizes Moderna and J&J boosters
It is now up to the CDC to decide whether to roll out booster shots for Moderna and Johnson & Johnson vaccine recipients, after the FDA authorized the additional doses Wednesday. The FDA also signed off on "mixing and matching" vaccines, allowing millions of Americans to get a different booster than their original shot. Nikki Battiste reports.
FDA advisers back J&J booster shot
A Food and Drug Administration advisory panel voted to endorse booster shots for Americans with Johnson & Johnson's COVID-19 vaccine. The recommendation came a day after the committee approved a third dose of Moderna's COVID-19 vaccine for seniors and high-risk adults. Michael George has the latest.
Children begin receiving Pfizer COVID vaccine
The CDC unanimously recommended Pfizer's low dose COVID-19 vaccine for kids ages 5 to 11. Drugstores like CVS and Walgreens are already setting up appointments, but some parents are hesitant about getting their kids vaccinated. Family medicine physician and CEO of CFP Physicians Group Dr. Adrian Burrowes joins CBSN's Lana Zak to discuss.
FDA authorizes Pfizer's COVID shot for kids
The Pfizer children's vaccine is about a third of the adult dose, but a clinical trial found it was nearly 91 percent effective at preventing COVID-19. If it gets final CDC approval next week, some 28 million children will be eligible for shots. Michael George has the latest.
FDA authorizes Pfizer vaccine for kids 5 to 11
The FDA authorized Pfizer's COVID vaccine for children ages 5 to 11, saying it was nearly 91% effective against symptomatic disease. Meg Oliver has the latest.
FDA authorizes Pfizer's pediatric COVID vaccine
The FDA has authorized Pfizer's COVID-19 vaccine for kids aged 5 to 11. Clinical trials found the smaller dose is 91% effective against the virus. Executive vice president of the Robert Wood Johnson Foundation Dr. Julie Morita joined CBSN's Lana Zak to discuss.
Live
Iran claims 4 tankers hit mines in Strait of Hormuz
Live
Live Updates: Trump campaigns in South Carolina and more
El-Sayed's faith, family under scrutiny in campaign. Here's what we know.
Hegseth fires Pentagon's top military planner over alleged leaks
Investigation
Whistleblower says DEA let fentanyl pills hit the streets
Russian strikes kill 16 in Ukraine but local truce brings some hope
Investigation
Classified material missing from Epstein files, documents suggest
King faces calls for apology, slavery reparations in Caribbean
